YDYun Dong

Yun Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yun Dong has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Doortje W. Dekens

    Department of Molecular Neurobiology, Faculty of Mathematics and Natural Sciences, University of Groningen, Groningen 9747 AG, The Netherlands

    1 shared publication
  • Peter Paul De Deyn

    Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    1 shared publication
  • Petrus J. W. Naudé

    Department of Molecular Neurobiology, Faculty of Mathematics and Natural Sciences, University of Groningen, Groningen 9747 AG, The Netherlands

    1 shared publication
  • Ulrich L. M. Eisel

    Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, the Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

    by Yun Dong, Doortje W. Dekens, Peter Paul De Deyn, Petrus J. W. Naudé, Ulrich L. M. Eisel

    Numerous studies have revealed the pleiotropic functions of tumor necrosis factor alpha (TNF-α), and have linked it with several neurodegenerative disorders. This review describes the signaling pathways induced by TNF-α via its two receptors (TNFR1 and TNFR2), and their functions in neurodegenerative processes as in Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and ischemic stroke. It has become clear that TNF-α may exert divergent actions in neurodegenerative disorders, including neurodegenerative and neuroprotective effects, which appear to depend on its signaling via either TNFR1 or TNFR2. Specific targeting of these receptors is a promising therapeutic strategy for many disorders.